In humans, NK cells comprise about 5–20% of peripheral blood lymphocytes, and they can directly eradicate the tumor cells by cytolysis, via granzyme B and perforin, or indirectly contribute by inducing an efficient T cell-mediated anti-tumor response [156]. Here, PRF1 is linked to neoplasm.